PepGen Inc. SEC filings PEPG
PepGen Inc. has 304 filings in SEC EDGAR's recent list, going back to Dec 9, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 21, 2026 | — |
| CORRESP | Letter to the SEC | May 19, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2026 | — |
| DRS | Filing | Apr 15, 2026 | — |
| EFFECT | Filing | Jul 8, 2024 | — |
| CORRESP | Letter to the SEC | Jul 3, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 2, 2024 | — |
| EFFECT | Filing | Jun 16, 2023 | — |
| CORRESP | Letter to the SEC | Jun 14, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2023 | — |
| SEC STAFF LETTER | Filing | May 16, 2022 | — |
| EFFECT | Filing | May 11, 2022 | — |
| EFFECT | Filing | May 5, 2022 | — |
| CERT | Filing | May 5, 2022 | — |
| CORRESP | Letter to the SEC | May 4, 2022 | — |
| UPLOAD | Letter from the SEC | May 3, 2022 | — |
| 8-A12B | Filing | May 3, 2022 | — |
| CORRESP | Letter to the SEC | May 3, 2022 | — |
| CORRESP | Letter to the SEC | May 3, 2022 | — |
| CORRESP | Letter to the SEC | May 2, 2022 | — |
| CORRESP | Letter to the SEC | Apr 22, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2022 | — |
| DRSLTR | Filing | Apr 8, 2022 | — |
| DRS/A | Filing | Apr 8, 2022 | — |
| SEC STAFF LETTER | Filing | Apr 7, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2022 | — |
| DRSLTR | Filing | Feb 11, 2022 | — |
| DRS/A | Filing | Feb 11, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 28, 2021 | — |
| DRS | Filing | Oct 1, 2021 | — |
| D | Filing | Aug 6, 2021 | — |
| D | Filing | Dec 9, 2020 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PEPG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1835597
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.